86 results on '"Croix, Brad St."'
Search Results
2. Disruption of anthrax toxin receptor 1 in pigs leads to a rare disease phenotype and protection from senecavirus A infection
3. An optimized bicistronic chimeric antigen receptor against GPC2 or CD276 overcomes heterogeneous expression in neuroblastoma
4. CAMEL NANOBODY-BASED B7-H3 CAR-T CELLS WITH HIGH EFFICACY AGAINST SOLID TUMORS
5. Abstract LB102: Hexyl-(cuban-1-yl-methyl)-biguanide (HCB) suppresses N-glycosylation of immune checkpoint proteins B7-H3 and B7-H4, reverses tumor hypoxia, decreases intratumoral regulatory T cells, and increases intratumoral CD8+ T cells in the ovarian dependent ER+HER2- SSM2ucd mammary cancer allograft model
6. Supplementary Figure 2 from A Human Single-Domain Antibody Elicits Potent Antitumor Activity by Targeting an Epitope in Mesothelin Close to the Cancer Cell Surface
7. Data from A Human Single-Domain Antibody Elicits Potent Antitumor Activity by Targeting an Epitope in Mesothelin Close to the Cancer Cell Surface
8. Supplementary Table 1 from A Human Single-Domain Antibody Elicits Potent Antitumor Activity by Targeting an Epitope in Mesothelin Close to the Cancer Cell Surface
9. Supplementary Figure 3 from A Human Single-Domain Antibody Elicits Potent Antitumor Activity by Targeting an Epitope in Mesothelin Close to the Cancer Cell Surface
10. Supplementary Figure 1 from A Human Single-Domain Antibody Elicits Potent Antitumor Activity by Targeting an Epitope in Mesothelin Close to the Cancer Cell Surface
11. Supplementary Table 2 from A Human Single-Domain Antibody Elicits Potent Antitumor Activity by Targeting an Epitope in Mesothelin Close to the Cancer Cell Surface
12. Supplementary Methods from A Human Single-Domain Antibody Elicits Potent Antitumor Activity by Targeting an Epitope in Mesothelin Close to the Cancer Cell Surface
13. Supplementary Data from CAR T Cells Targeting B7-H3, a Pan-Cancer Antigen, Demonstrate Potent Preclinical Activity Against Pediatric Solid Tumors and Brain Tumors
14. Supplementary Data from The B7-H3–Targeting Antibody–Drug Conjugate m276-SL-PBD Is Potently Effective Against Pediatric Cancer Preclinical Solid Tumor Models
15. Supplementary Figure 1 from Hypoxia-Inducible Factor-1 Target Genes as Indicators of Tumor Vessel Response to Vascular Endothelial Growth Factor Inhibition
16. Data from Hypoxia-Inducible Factor-1 Target Genes as Indicators of Tumor Vessel Response to Vascular Endothelial Growth Factor Inhibition
17. Tumor Endothelial Markers
18. Cancer cell survival depends on collagen uptake into tumor-associated stroma
19. Tumor endothelial marker 1 (Tem1) Functions in the Growth and Progression of Abdominal Tumors
20. Abstract 1498: Nanobody-based CAR T cells targeting B7-H3 in pancreatic cancer
21. The B7-H3–Targeting Antibody–Drug Conjugate m276-SL-PBD Is Potently Effective Against Pediatric Cancer Preclinical Solid Tumor Models
22. Novel metabolic role for BDNF in pancreatic β-cell insulin secretion
23. Antxr1, Which is a Target of Runx2, Regulates Chondrocyte Proliferation and Apoptosis
24. Large-scale identification of novel transcripts in the human genome
25. Antxr1, Which is a Target of Runx2, Regulates Chondrocyte Proliferation and Apoptosis
26. A Phosphatase Associated with Metastasis of Colorectal Cancer
27. Genes Expressed in Human Tumor Endothelium
28. Isolation of rabbit single domain antibodies to B7-H3 via protein immunization and phage display
29. Abstract C003: Initial testing of m276-PBD CD276 antibody-drug conjugate in preclinical models of pediatric cancers by the Pediatric Preclinical Testing Consortium (PPTC)
30. CAR T Cells Targeting B7-H3, a Pan-Cancer Antigen, Demonstrate Potent Preclinical Activity Against Pediatric Solid Tumors and Brain Tumors
31. Abstract A25: TEM8 specific CAR T cells induce regression of patient-derived xenograft and metastatic models of triple-negative breast cancer
32. Improving VEGF-targeted therapies through inhibition of COX-2/PGE2signaling
33. Chemoprevention of metastasis
34. A Human Single-Domain Antibody Elicits Potent Antitumor Activity by Targeting an Epitope in Mesothelin Close to the Cancer Cell Surface
35. Hypoxia-Inducible Factor-1 Target Genes as Indicators of Tumor Vessel Response to Vascular Endothelial Growth Factor Inhibition
36. Serial Analysis of Gene Expression (SAGE): Experimental Method and Data Analysis
37. Serial Analysis of Gene Expression (SAGE)
38. COX-2 Inhibition Potentiates Antiangiogenic Cancer Therapy and Prevents Metastasis in Preclinical Models.
39. Impact of oncogenes in tumor angiogenesis: Mutant K- ras up-regulation of vascular endothelial growth factor/vascular permeability factor is necessary, but not sufficient for tumorigenicity of human colorectal carcinoma cells
40. Engineering CD276/B7-H3-targeted antibody-drug conjugates with enhanced cancer-eradicating capability
41. Cell adhesion and drug resistance in cancer
42. Impact of the cyclin–dependent kinase inhibitor p27Kip1 on resistance of tumor cells to anticancer agents
43. Selective blockade of tumor angiogenesis.
44. GPR124, an orphan G protein-coupled receptor, is required for CNS-specific vascularization and establishment of the blood-brain barrier.
45. Transcriptional response to hypoxia in human tumors.
46. The Imperial Army Project: Britain and the Land Forces of the Dominions and India, 1902-1945.
47. Impact of the cyclin-dependent kinase inhibitor p27Kip1 on resistance of tumor cells to anticancer agents.
48. The Endless Battle: The Fall of Hong Kong and Canadian POWs in Imperial Japan.
49. Impact of the cyclin–dependent kinase inhibitor p27Kip1on resistance of tumor cells to anticancer agents
50. The British Commonwealth and Victory in the Second World War.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.